Le Lézard
Classified in: Health
Subjects: HEALTH, Philanthropy, Contests/Awards

Diabetes Canada awards $9 million in funding to 30 new research projects

Toronto, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Diabetes Canada is proud to announce the winners of our End Diabetes Awards research competition. Each of the winning research projects has the potential to unlock new insights and breakthroughs in the field of diabetes management, care, and risk-reduction. These investigator-driven projects span biomedical, clinical, health services and population health research?and all aim to dramatically improve the lives of people living with type 1 and type 2 diabetes.

"Canada has a well-earned reputation for innovation in diabetes treatment and care that has dramatically improved the quality of life for people with diabetes," says Laura Syron, President and CEO of Diabetes Canada. "Diabetes Canada is excited to invest in these researchers and their teams as they work to advance new discoveries and the next big breakthrough in diabetes care."

From a project that is probing into the systemic health inequities that prevent high-risk communities from accessing life-saving technologies to a study that is exploring the possibility of delaying type 1 diabetes by resetting the immune system, these research projects are uncovering new and pioneering ways to tackle the growing burden of diabetes in Canada.

To end diabetes, we need to harness the transformative and combined power of technological, medical, and scientific research. That is why Diabetes Canada has committed $9 million in funds to the research community, ensuring that each of these 30 promising projects receive a $100,000 grant annually for three years.

The winning projects were rigorously evaluated by scientists with expertise in diabetes research, with input from people with lived experience, as well as our National Research Council.

 "The diversity and strength of diabetes research in Canada can't be overstated," says Dr. Rob Screaton, Co-Chair of Diabetes Canada's National Research Council. "These new awards will energize the dynamic research community and add to the growing excitement about identifying new treatments for people living with diabetes on the immediate horizon."

"On behalf of Diabetes Canada and the millions of people in Canada currently living with diabetes, including myself, I would like to recognize the support of our incredible community of donors, without which this research funding would simply not be possible," says Laura Syron.

Diabetes Canada currently supports 55 research projects from 15 research institutions and labs located across the country.


About Diabetes Canada

A world free of the effects of diabetes is our vision. That's why we're working together to improve the quality of life of people living with diabetes. We're sharing knowledge and creating connections for individuals and the health-care professionals who care for them; advocating through public policy; and funding research to improve treatments and find a cure to end diabetes.?? 


These press releases may also interest you

at 22:15
The "Healthcare E-Commerce Global Market Report 2023" report has been added to  ResearchAndMarkets.com's offering. This report provides strategists, marketers and senior management with the critical information they need to assess the market. The...

at 22:00
The bacterial disease diagnostics market size is forecast to grow by USD 3,766.05 million between 2022 and 2027. However, the growth momentum will be decelerating at a CAGR of 6.28% during the forecast period. The growth of the market is driven by...

at 21:18
Avirmax CMC Inc. (ACI), a cGMP-licensed CDMO, is announcing the implementation of its newly-developed Sf rhabdovirus-free cell lines (under the generic trademark of Sf-RVFtm) developed for producing recombinant adeno-associated viral vectors (rAAV)....

at 20:35
Biogen Inc.  announced today the outcome of the U.S. Food and Drug Administration's (FDA) Peripheral and Central Nervous System Drugs Advisory Committee meeting on tofersen, an investigational product for the treatment of superoxide dismutase 1...

at 20:30
The "Global Gene Editing Partnering Terms and Agreements 2010 to 2023" report has been added to  ResearchAndMarkets.com's offering. The Global Gene Editing Partnering Terms and Agreements 2010-2023 report provides an understanding and access to 400+...

at 20:01
Huma's platform is ready to use, reducing the time and cost for other companies to bring regulated SaMD products to market, democratising digital health innovation across the industryClass IIb certification expands the patient population and level of...

News published on 17 january 2023 at 07:00 and distributed by: